| Year |
Citation |
Score |
| 2021 |
Sawa M, Overk C, Becker A, Derse D, Albay R, Weldy K, Salehi A, Beach TG, Doran E, Head E, Yu YE, Mobley WC. Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34757693 DOI: 10.1002/alz.12463 |
0.588 |
|
| 2020 |
Chen XQ, Salehi A, Pearn ML, Overk C, Nguyen PD, Kleschevnikov AM, Maccecchini M, Mobley WC. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32975365 DOI: 10.1002/alz.12185 |
0.593 |
|
| 2020 |
Johnstone A, Mobley W. Local TrkB signaling: themes in development and neural plasticity. Cell and Tissue Research. 382: 101-111. PMID 32936344 DOI: 10.1007/S00441-020-03278-7 |
0.364 |
|
| 2020 |
Qian H, Kang X, Hu J, Zhang D, Liang Z, Meng F, Zhang X, Xue Y, Maimon R, Dowdy SF, Devaraj NK, Zhou Z, Mobley WC, Cleveland DW, Fu XD. Author Correction: Reversing a model of Parkinson's disease with in situ converted nigral neurons. Nature. PMID 32724206 DOI: 10.1038/S41586-020-2583-3 |
0.306 |
|
| 2020 |
Stupack J, Xiong XP, Jiang LL, Zhang T, Zhou L, Campos A, Ranscht B, Mobley W, Pasquale EB, Xu H, Huang TY. Soluble SORLA enhances neurite outgrowth and regeneration through activation of the EGF Receptor/ERK signaling axis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32601248 DOI: 10.1523/Jneurosci.0723-20.2020 |
0.416 |
|
| 2020 |
Qian H, Kang X, Hu J, Zhang D, Liang Z, Meng F, Zhang X, Xue Y, Maimon R, Dowdy SF, Devaraj NK, Zhou Z, Mobley WC, Cleveland DW, Fu XD. Reversing a model of Parkinson's disease with in situ converted nigral neurons. Nature. 582: 550-556. PMID 32581380 DOI: 10.1038/S41586-020-2388-4 |
0.361 |
|
| 2020 |
Snyder HM, Bain LJ, Brickman AM, Carrillo MC, Esbensen AJ, Espinosa JM, Fernandez F, Fortea J, Hartley SL, Head E, Hendrix J, Kishnani PS, Lai F, Lao P, Lemere C, ... Mobley W, et al. Further understanding the connection between Alzheimer's disease and Down syndrome. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32544310 DOI: 10.1002/Alz.12112 |
0.328 |
|
| 2020 |
Kaplan DR, Mobley WC. (H)Elping nerve growth factor: Elp1 inhibits TrkA's phosphatase to maintain retrograde signaling. The Journal of Clinical Investigation. PMID 32281945 DOI: 10.1172/Jci136162 |
0.412 |
|
| 2020 |
Decourt B, Mobley W, Reiman E, Shah RJ, Sabbagh MN. Recent Perspectives on APP, Secretases, Endosomal Pathways and How they Influence Alzheimer's Related Pathological Changes in Down Syndrome. Journal of Alzheimer's Disease & Parkinsonism. 002. PMID 24782952 DOI: 10.4172/2161-0460.S7-002 |
0.343 |
|
| 2019 |
Chen XQ, Mobley WC. Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species. Frontiers in Neuroscience. 13: 659. PMID 31293377 DOI: 10.3389/Fnins.2019.00659 |
0.325 |
|
| 2019 |
Chen XQ, Mobley WC. Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons: Converging Insights From Alternative Hypotheses. Frontiers in Neuroscience. 13: 446. PMID 31133787 DOI: 10.3389/Fnins.2019.00446 |
0.397 |
|
| 2019 |
Escudero CA, Cabeza C, Moya-Alvarado G, Maloney MT, Flores CM, Wu C, Court FA, Mobley WC, Bronfman FC. c-Jun N-terminal kinase (JNK)-dependent internalization and Rab5-dependent endocytic sorting mediate long-distance retrograde neuronal death induced by axonal BDNF-p75 signaling. Scientific Reports. 9: 6070. PMID 30988348 DOI: 10.1038/S41598-019-42420-6 |
0.381 |
|
| 2018 |
Chen XQ, Fang F, Florio JB, Rockenstein E, Masliah E, Mobley WC, Rissman RA, Wu C. TRiC enhances retrograde axonal transport by modulating tau phosphorylation. Traffic (Copenhagen, Denmark). PMID 30120810 DOI: 10.1111/Tra.12610 |
0.349 |
|
| 2018 |
Pearn ML, Schilling JM, Jian M, Egawa J, Wu C, Mandyam CD, Fannon-Pavlich MJ, Nguyen U, Bertoglio J, Kodama M, Mahata SK, DerMardirossian C, Lemkuil BP, Han R, Mobley WC, et al. Inhibition of RhoA reduces propofol-mediated growth cone collapse, axonal transport impairment, loss of synaptic connectivity, and behavioural deficits. British Journal of Anaesthesia. 120: 745-760. PMID 29576115 DOI: 10.1016/J.Bja.2017.12.033 |
0.362 |
|
| 2018 |
Sung K, Ferrari LF, Yang W, Chung C, Zhao X, Gu Y, Lin S, Zhang K, Cui B, Pearn ML, Maloney MT, Mobley WC, Levine JD, Wu C. Swedish Nerve Growth Factor Mutation (NGF) Defines a Role for TrkA and p75in Nociception. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29483280 DOI: 10.1523/Jneurosci.1686-17.2018 |
0.411 |
|
| 2017 |
Chen XQ, Sawa M, Mobley WC. Dysregulation of Neurotrophin Signaling in the Pathogenesis of Alzheimer Disease and of Alzheimer Disease in Down Syndrome. Free Radical Biology & Medicine. PMID 29031834 DOI: 10.1016/J.Freeradbiomed.2017.10.341 |
0.398 |
|
| 2017 |
Rafii MS, Lukic AS, Andrews RD, Brewer J, Rissman RA, Strother SC, Wernick MN, Pennington C, Mobley WC, Ness S, Matthews DC. PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI). Journal of Alzheimer's Disease : Jad. 60: 439-450. PMID 28946567 DOI: 10.3233/Jad-170390 |
0.322 |
|
| 2017 |
Bradshaw RA, Mobley W, Rush RA. Nerve Growth Factor and Related Substances: A Brief History and an Introduction to the International NGF Meeting Series. International Journal of Molecular Sciences. 18. PMID 28587118 DOI: 10.3390/Ijms18061143 |
0.374 |
|
| 2017 |
Wagner SL, Rynearson KD, Duddy SK, Zhang C, Nguyen PD, Becker A, Vo U, Masliah D, Monte L, Klee JB, Echmalian CM, Xia W, Quinti L, Johnson G, Lin JH, ... ... Mobley WC, et al. Pharmacological and Toxicological Properties of the Potent Oral γ-Secretase Modulator BPN-15606. The Journal of Pharmacology and Experimental Therapeutics. PMID 28416568 DOI: 10.1124/Jpet.117.240861 |
0.3 |
|
| 2017 |
Kleschevnikov AM, Yu J, Kim J, Lysenko LV, Zhen Z, Eugene Yu Y, Mobley WC. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome. Neurobiology of Disease. PMID 28342823 DOI: 10.1016/J.Nbd.2017.03.009 |
0.331 |
|
| 2016 |
Matthews DC, Lukic AS, Andrews RD, Marendic B, Brewer J, Rissman RA, Mosconi L, Strother SC, Wernick MN, Mobley WC, Ness S, Schmidt ME, Rafii MS. Dissociation of Down syndrome and Alzheimer's disease effects with imaging. Alzheimer's & Dementia (New York, N. Y.). 2: 69-81. PMID 28642933 DOI: 10.1016/J.Trci.2016.02.004 |
0.323 |
|
| 2016 |
Mojabi FS, Fahimi A, Moghadam S, Moghadam S, McNerneny MW, Ponnusamy R, Kleschevnikov A, Mobley WC, Salehi A. GABAergic Hyperinnervation of Dentate Granule Cells in the Ts65Dn Mouse Model of Down Syndrome Exploring the Role of App. Hippocampus. PMID 27701794 DOI: 10.1002/Hipo.22664 |
0.78 |
|
| 2016 |
Zhao X, Chen XQ, Han E, Hu Y, Paik P, Ding Z, Overman J, Lau AL, Shahmoradian SH, Chiu W, Thompson LM, Wu C, Mobley WC. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 27601642 DOI: 10.1073/Pnas.1603020113 |
0.39 |
|
| 2016 |
Ballard C, Mobley W, Hardy J, Williams G, Corbett A. Dementia in Down's syndrome. The Lancet. Neurology. 15: 622-36. PMID 27302127 DOI: 10.1016/S1474-4422(16)00063-6 |
0.309 |
|
| 2016 |
Xu W, Weissmiller AM, White JA, Fang F, Wang X, Wu Y, Pearn ML, Zhao X, Sawa M, Chen S, Gunawardena S, Ding J, Mobley WC, Wu C. Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration. The Journal of Clinical Investigation. PMID 27064279 DOI: 10.1172/Jci82409 |
0.759 |
|
| 2016 |
Belichenko PV, Madani R, Rey-Bellet L, Pihlgren M, Becker A, Plassard A, Vuillermot S, Giriens V, Nosheny RL, Kleschevnikov AM, Valletta JS, Bengtsson SK, Linke GR, Maloney MT, Hickman DT, ... ... Mobley WC, et al. An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome. Plos One. 11: e0152471. PMID 27023444 DOI: 10.1371/Journal.Pone.0152471 |
0.334 |
|
| 2015 |
Rafii MS, Wishnek H, Brewer JB, Donohue MC, Ness S, Mobley WC, Aisen PS, Rissman RA. The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome. Frontiers in Behavioral Neuroscience. 9: 239. PMID 26441570 DOI: 10.3389/Fnbeh.2015.00239 |
0.302 |
|
| 2015 |
Jiang X, Liu C, Yu T, Zhang L, Meng K, Xing Z, Belichenko PV, Pao A, Peresie J, Wie S, Mobley WC, Yu YE. Genetic Dissection of the Down Syndrome Critical Region. Human Molecular Genetics. PMID 26374847 DOI: 10.1093/Hmg/Ddv364 |
0.313 |
|
| 2015 |
Zhao Y, Tseng IC, Heyser CJ, Rockenstein E, Mante M, Adame A, Zheng Q, Huang T, Wang X, Arslan PE, Chakrabarty P, Wu C, Bu G, Mobley WC, Zhang YW, et al. Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis. Neuron. 87: 963-75. PMID 26335643 DOI: 10.1016/J.Neuron.2015.08.020 |
0.304 |
|
| 2015 |
Belichenko PV, Kleschevnikov AM, Becker A, Wagner GE, Lysenko LV, Yu YE, Mobley WC. Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues. Plos One. 10: e0134861. PMID 26230397 DOI: 10.1371/Journal.Pone.0134861 |
0.321 |
|
| 2015 |
Selfridge A, Hyun N, Chiang CC, Reyna SM, Weissmiller AM, Shi LZ, Preece D, Mobley WC, Berns MW. Rat embryonic hippocampus and induced pluripotent stem cell derived cultured neurons recover from laser-induced subaxotomy. Neurophotonics. 2: 015006. PMID 26157985 DOI: 10.1117/1.Nph.2.1.015006 |
0.724 |
|
| 2015 |
Nosheny RL, Belichenko PV, Busse BL, Weissmiller AM, Dang V, Das D, Fahimi A, Salehi A, Smith SJ, Mobley WC. Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome. Neurobiology of Disease. 77: 173-90. PMID 25753471 DOI: 10.1016/J.Nbd.2015.02.022 |
0.771 |
|
| 2015 |
Weissmiller AM, Natera-Naranjo O, Reyna SM, Pearn ML, Zhao X, Nguyen P, Cheng S, Goldstein LS, Tanzi RE, Wagner SL, Mobley WC, Wu C. A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP. Plos One. 10: e0118379. PMID 25710492 DOI: 10.1371/Journal.Pone.0118379 |
0.759 |
|
| 2015 |
Hartley D, Blumenthal T, Carrillo M, DiPaolo G, Esralew L, Gardiner K, Granholm AC, Iqbal K, Krams M, Lemere C, Lott I, Mobley W, Ness S, Nixon R, Potter H, et al. Down syndrome and Alzheimer's disease: Common pathways, common goals. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 700-9. PMID 25510383 DOI: 10.1016/J.Jalz.2014.10.007 |
0.341 |
|
| 2014 |
Fargo KN, Aisen P, Albert M, Au R, Corrada MM, DeKosky S, Drachman D, Fillit H, Gitlin L, Haas M, Herrup K, Kawas C, Khachaturian AS, Khachaturian ZS, ... ... Mobley W, et al. 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S430-52. PMID 25341459 DOI: 10.1016/J.Jalz.2014.08.103 |
0.517 |
|
| 2014 |
Zhao X, Zhou Y, Weissmiller AM, Pearn ML, Mobley WC, Wu C. Real-time imaging of axonal transport of quantum dot-labeled BDNF in primary neurons. Journal of Visualized Experiments : Jove. 51899. PMID 25286194 DOI: 10.3791/51899 |
0.732 |
|
| 2014 |
Shahmoradian SH, Galiano MR, Wu C, Chen S, Rasband MN, Mobley WC, Chiu W. Preparation of primary neurons for visualizing neurites in a frozen-hydrated state using cryo-electron tomography. Journal of Visualized Experiments : Jove. e50783. PMID 24561719 DOI: 10.3791/50783 |
0.345 |
|
| 2014 |
Zhang L, Meng K, Jiang X, Liu C, Pao A, Belichenko PV, Kleschevnikov AM, Josselyn S, Liang P, Ye P, Mobley WC, Yu YE. Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits. Human Molecular Genetics. 23: 578-89. PMID 24041763 DOI: 10.1093/Hmg/Ddt446 |
0.322 |
|
| 2013 |
Zhang H, Petit GH, Gaughwin PM, Hansen C, Ranganathan S, Zuo X, Smith R, Roybon L, Brundin P, Mobley WC, Li JY. NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease. Journal of Huntington's Disease. 2: 69-82. PMID 25063430 DOI: 10.3233/Jhd-120026 |
0.419 |
|
| 2013 |
Ruparelia A, Pearn ML, Mobley WC. Aging and intellectual disability: insights from mouse models of Down syndrome. Developmental Disabilities Research Reviews. 18: 43-50. PMID 23949828 DOI: 10.1002/Ddrr.1127 |
0.335 |
|
| 2013 |
Wang X, Zhao Y, Zhang X, Badie H, Zhou Y, Mu Y, Loo LS, Cai L, Thompson RC, Yang B, Chen Y, Johnson PF, Wu C, Bu G, Mobley WC, et al. Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome. Nature Medicine. 19: 473-80. PMID 23524343 DOI: 10.1038/Nm.3117 |
0.376 |
|
| 2013 |
Wang X, Zhao Y, Zhang X, Zhou Y, Ranscht B, Gage FH, Mobley WC, Zhang Y, Lipton SA, Hong W, Xu H. A novel mechanism underlying pathogenesis of Down syndrome Molecular Neurodegeneration. 8: O23. DOI: 10.1186/1750-1326-8-S1-O23 |
0.329 |
|
| 2012 |
Kleschevnikov AM, Belichenko PV, Faizi M, Jacobs LF, Htun K, Shamloo M, Mobley WC. Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 9217-27. PMID 22764230 DOI: 10.1523/Jneurosci.1673-12.2012 |
0.323 |
|
| 2012 |
Ruparelia A, Pearn ML, Mobley WC. Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome. Current Opinion in Neurobiology. 22: 880-6. PMID 22658745 DOI: 10.1016/J.Conb.2012.05.002 |
0.322 |
|
| 2012 |
Zhang L, Fu D, Belichenko PV, Liu C, Kleschevnikov AM, Pao A, Liang P, Clapcote SJ, Mobley WC, Yu YE. Genetic analysis of Down syndrome facilitated by mouse chromosome engineering. Bioengineered Bugs. 3: 8-12. PMID 22126738 DOI: 10.4161/Bbug.3.1.17696 |
0.317 |
|
| 2012 |
Kleschevnikov AM, Belichenko PV, Gall J, George L, Nosheny R, Maloney MT, Salehi A, Mobley WC. Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome. Neurobiology of Disease. 45: 683-91. PMID 22062771 DOI: 10.1016/J.Nbd.2011.10.009 |
0.63 |
|
| 2011 |
Liu C, Belichenko PV, Zhang L, Fu D, Kleschevnikov AM, Baldini A, Antonarakis SE, Mobley WC, Yu YE. Mouse models for Down syndrome-associated developmental cognitive disabilities. Developmental Neuroscience. 33: 404-13. PMID 21865664 DOI: 10.1159/000329422 |
0.32 |
|
| 2011 |
Faizi M, Bader PL, Tun C, Encarnacion A, Kleschevnikov A, Belichenko P, Saw N, Priestley M, Tsien RW, Mobley WC, Shamloo M. Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer. Neurobiology of Disease. 43: 397-413. PMID 21527343 DOI: 10.1016/J.Nbd.2011.04.011 |
0.329 |
|
| 2011 |
Rissman RA, Mobley WC. Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease. Journal of Neurochemistry. 117: 613-22. PMID 21388375 DOI: 10.1111/J.1471-4159.2011.07237.X |
0.328 |
|
| 2010 |
Yu T, Liu C, Belichenko P, Clapcote SJ, Li S, Pao A, Kleschevnikov A, Bechard AR, Asrar S, Chen R, Fan N, Zhou Z, Jia Z, Chen C, Roder JC, ... ... Mobley WC, et al. Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice. Brain Research. 1366: 162-71. PMID 20932954 DOI: 10.1016/J.Brainres.2010.09.107 |
0.302 |
|
| 2010 |
Kounnas MZ, Danks AM, Cheng S, Tyree C, Ackerman E, Zhang X, Ahn K, Nguyen P, Comer D, Mao L, Yu C, Pleynet D, Digregorio PJ, Velicelebi G, Stauderman KA, ... ... Mobley WC, et al. Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease. Neuron. 67: 769-80. PMID 20826309 DOI: 10.1016/J.Neuron.2010.08.018 |
0.3 |
|
| 2010 |
Yu T, Clapcote SJ, Li Z, Liu C, Pao A, Bechard AR, Carattini-Rivera S, Matsui S, Roder JC, Baldini A, Mobley WC, Bradley A, Yu YE. Deficiencies in the region syntenic to human 21q22.3 cause cognitive deficits in mice. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 21: 258-67. PMID 20512340 DOI: 10.1007/S00335-010-9262-X |
0.309 |
|
| 2009 |
Salehi A, Faizi M, Colas D, Valletta J, Laguna J, Takimoto-Kimura R, Kleschevnikov A, Wagner SL, Aisen P, Shamloo M, Mobley WC. Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome. Science Translational Medicine. 1: 7ra17. PMID 20368182 DOI: 10.1126/Scitranslmed.3000258 |
0.641 |
|
| 2009 |
Tamaki SJ, Jacobs Y, Dohse M, Capela A, Cooper JD, Reitsma M, He D, Tushinski R, Belichenko PV, Salehi A, Mobley W, Gage FH, Huhn S, Tsukamoto AS, Weissman IL, et al. Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis. Cell Stem Cell. 5: 310-9. PMID 19733542 DOI: 10.1016/J.Stem.2009.05.022 |
0.641 |
|
| 2009 |
Belichenko NP, Belichenko PV, Kleschevnikov AM, Salehi A, Reeves RH, Mobley WC. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 5938-48. PMID 19420260 DOI: 10.1523/Jneurosci.1547-09.2009 |
0.641 |
|
| 2009 |
Belichenko PV, Wright EE, Belichenko NP, Masliah E, Li HH, Mobley WC, Francke U. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. The Journal of Comparative Neurology. 514: 240-58. PMID 19296534 DOI: 10.1002/Cne.22009 |
0.353 |
|
| 2009 |
Belichenko NP, Belichenko PV, Mobley WC. Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation. Neurobiology of Disease. 34: 71-7. PMID 19167498 DOI: 10.1016/J.Nbd.2008.12.016 |
0.348 |
|
| 2009 |
Belichenko PV, Kleschevnikov AM, Masliah E, Wu C, Takimoto-Kimura R, Salehi A, Mobley WC. Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome. The Journal of Comparative Neurology. 512: 453-66. PMID 19034952 DOI: 10.1002/Cne.21895 |
0.629 |
|
| 2009 |
Wu C, Cui B, He L, Chen L, Mobley WC. The coming of age of axonal neurotrophin signaling endosomes. Journal of Proteomics. 72: 46-55. PMID 19028611 DOI: 10.1016/J.Jprot.2008.10.007 |
0.381 |
|
| 2008 |
Wan J, Cheung AY, Fu WY, Wu C, Zhang M, Mobley WC, Cheung ZH, Ip NY. Endophilin B1 as a novel regulator of nerve growth factor/ TrkA trafficking and neurite outgrowth. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 9002-12. PMID 18768694 DOI: 10.1523/Jneurosci.0767-08.2008 |
0.389 |
|
| 2008 |
Belichenko NP, Belichenko PV, Li HH, Mobley WC, Francke U. Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome. The Journal of Comparative Neurology. 508: 184-95. PMID 18306326 DOI: 10.1002/Cne.21673 |
0.319 |
|
| 2008 |
Kleschevnikov AM, Belichenko PV, Mobley W. P1-036: Suppression of GABAB receptors increases LTP without inducing pro-epileptic activity in the dentate gyrus of Ts65Dn mice, a genetic model for Down syndrome Alzheimer's & Dementia. 4: T216-T216. DOI: 10.1016/J.Jalz.2008.05.621 |
0.323 |
|
| 2008 |
Salehi A, Faizi M, Takimoto R, Valletta J, Danks A, Mobley WC. P2-308: Examining the effects of (+)-phenserine in Ts65Dn mouse model of down syndrome Alzheimer's & Dementia. 4: T462-T463. DOI: 10.1016/J.Jalz.2008.05.1385 |
0.604 |
|
| 2007 |
Salehi A, Faizi M, Belichenko PV, Mobley WC. Using mouse models to explore genotype-phenotype relationship in Down syndrome. Mental Retardation and Developmental Disabilities Research Reviews. 13: 207-14. PMID 17910089 DOI: 10.1002/Mrdd.20164 |
0.653 |
|
| 2007 |
Wu C, Ramirez A, Cui B, Ding J, Delcroix JD, Valletta JS, Liu JJ, Yang Y, Chu S, Mobley WC. A functional dynein-microtubule network is required for NGF signaling through the Rap1/MAPK pathway. Traffic (Copenhagen, Denmark). 8: 1503-20. PMID 17822405 DOI: 10.1111/J.1600-0854.2007.00636.X |
0.397 |
|
| 2007 |
Cui B, Wu C, Chen L, Ramirez A, Bearer EL, Li WP, Mobley WC, Chu S. One at a time, live tracking of NGF axonal transport using quantum dots. Proceedings of the National Academy of Sciences of the United States of America. 104: 13666-71. PMID 17698956 DOI: 10.1073/Pnas.0706192104 |
0.395 |
|
| 2007 |
Belichenko PV, Kleschevnikov AM, Salehi A, Epstein CJ, Mobley WC. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships. The Journal of Comparative Neurology. 504: 329-45. PMID 17663443 DOI: 10.1002/Cne.21433 |
0.634 |
|
| 2007 |
Liu JJ, Ding J, Wu C, Bhagavatula P, Cui B, Chu S, Mobley WC, Yang Y. Retrolinkin, a membrane protein, plays an important role in retrograde axonal transport. Proceedings of the National Academy of Sciences of the United States of America. 104: 2223-8. PMID 17287360 DOI: 10.1073/Pnas.0602222104 |
0.316 |
|
| 2007 |
Salehi A, Kleshevnikov A, Mobley WC. Cholinergic neurodegeneration in Alzheimer's disease: Basis for nerve growth factor therapy Pharmacological Mechanisms in Alzheimer's Therapeutics. 64-104. DOI: 10.1007/978-0-387-71522-3_5 |
0.597 |
|
| 2006 |
Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, ... ... Mobley WC, et al. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron. 51: 29-42. PMID 16815330 DOI: 10.1016/J.Neuron.2006.05.022 |
0.691 |
|
| 2006 |
Miyamoto Y, Yamauchi J, Tanoue A, Wu C, Mobley WC. TrkB binds and tyrosine-phosphorylates Tiam1, leading to activation of Rac1 and induction of changes in cellular morphology. Proceedings of the National Academy of Sciences of the United States of America. 103: 10444-9. PMID 16801538 DOI: 10.1073/Pnas.0603914103 |
0.376 |
|
| 2006 |
Ding J, Allen E, Wang W, Valle A, Wu C, Nardine T, Cui B, Yi J, Taylor A, Jeon NL, Chu S, So Y, Vogel H, Tolwani R, Mobley W, et al. Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport. Human Molecular Genetics. 15: 1451-63. PMID 16565160 DOI: 10.1093/Hmg/Ddl069 |
0.36 |
|
| 2006 |
Watson G, Bastacky J, Belichenko P, Buddhikot M, Jungles S, Vellard M, Mobley WC, Kakkis E. Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice. Gene Therapy. 13: 917-25. PMID 16482204 DOI: 10.1038/Sj.Gt.3302735 |
0.306 |
|
| 2005 |
Villar AJ, Belichenko PV, Gillespie AM, Kozy HM, Mobley WC, Epstein CJ. Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(171)65Dn and mouse chromosome 12. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 16: 79-90. PMID 15859352 DOI: 10.1007/S00335-004-2428-7 |
0.319 |
|
| 2005 |
Howe CL, Mobley WC. Long-distance retrograde neurotrophic signaling. Current Opinion in Neurobiology. 15: 40-8. PMID 15721743 DOI: 10.1016/J.Conb.2005.01.010 |
0.622 |
|
| 2004 |
Belichenko PV, Masliah E, Kleschevnikov AM, Villar AJ, Epstein CJ, Salehi A, Mobley WC. Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome. The Journal of Comparative Neurology. 480: 281-98. PMID 15515178 DOI: 10.1002/Cne.20337 |
0.638 |
|
| 2004 |
Pontikis CC, Cella CV, Parihar N, Lim MJ, Chakrabarti S, Mitchison HM, Mobley WC, Rezaie P, Pearce DA, Cooper JD. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation. Brain Research. 1023: 231-42. PMID 15374749 DOI: 10.1016/J.Brainres.2004.07.030 |
0.374 |
|
| 2004 |
Kleschevnikov AM, Belichenko PV, Villar AJ, Epstein CJ, Malenka RC, Mobley WC. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 8153-60. PMID 15371516 DOI: 10.1523/Jneurosci.1766-04.2004 |
0.34 |
|
| 2004 |
Reichardt LF, Mobley WC. Going the distance, or not, with neurotrophin signals. Cell. 118: 141-3. PMID 15260984 DOI: 10.1016/J.Cell.2004.07.008 |
0.424 |
|
| 2004 |
Howe CL, Mobley WC. Signaling endosome hypothesis: A cellular mechanism for long distance communication. Journal of Neurobiology. 58: 207-16. PMID 14704953 DOI: 10.1002/Neu.10323 |
0.577 |
|
| 2004 |
Delcroix JD, Valletta J, Wu C, Howe CL, Lai CF, Cooper JD, Belichenko PV, Salehi A, Mobley WC. Trafficking the NGF signal: implications for normal and degenerating neurons. Progress in Brain Research. 146: 3-23. PMID 14699953 DOI: 10.1016/S0079-6123(03)46001-9 |
0.75 |
|
| 2004 |
Kleschevnikov AM, Belichenko PV, Epstein CJ, Villar AJ, Malenka R, Mobley WC. P2-101 Reduced LTP and enhanced inhibition in dentate gyrus of TS65DN mice, a model for down's syndrome Neurobiology of Aging. 25: S252. DOI: 10.1016/S0197-4580(04)80848-0 |
0.316 |
|
| 2004 |
Salehi A, Delcroix J, Xia W, Sambamurti K, Mobley WC. P1-254 APP and β-amyloid levels in segmental trisomy mouse model of down syndrome Neurobiology of Aging. 25: S168. DOI: 10.1016/S0197-4580(04)80567-0 |
0.602 |
|
| 2004 |
Delcroix J, Salehi A, Mobley W. S4-01-03 Trafficking the target-derived signals of neurotrophic factors: implications for normal and degenerating neurons Neurobiology of Aging. 25: S67. DOI: 10.1016/S0197-4580(04)80227-6 |
0.648 |
|
| 2003 |
Liu JJ, Ding J, Kowal AS, Nardine T, Allen E, Delcroix JD, Wu C, Mobley W, Fuchs E, Yang Y. BPAG1n4 is essential for retrograde axonal transport in sensory neurons. The Journal of Cell Biology. 163: 223-9. PMID 14581450 DOI: 10.1083/Jcb.200306075 |
0.356 |
|
| 2003 |
Delcroix JD, Valletta JS, Wu C, Hunt SJ, Kowal AS, Mobley WC. NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron. 39: 69-84. PMID 12848933 DOI: 10.1016/S0896-6273(03)00397-0 |
0.411 |
|
| 2003 |
Salehi A, Delcroix JD, Mobley WC. Traffic at the intersection of neurotrophic factor signaling and neurodegeneration. Trends in Neurosciences. 26: 73-80. PMID 12536130 DOI: 10.1016/S0166-2236(02)00038-3 |
0.677 |
|
| 2001 |
Howe CL, Valletta JS, Rusnak AS, Mobley WC. NGF signaling from clathrin-coated vesicles: evidence that signaling endosomes serve as a platform for the Ras-MAPK pathway. Neuron. 32: 801-14. PMID 11738027 DOI: 10.1016/S0896-6273(01)00526-8 |
0.632 |
|
| 2001 |
Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annual Review of Neuroscience. 24: 1217-81. PMID 11520933 DOI: 10.1146/Annurev.Neuro.24.1.1217 |
0.648 |
|
| 2001 |
Cooper JD, Salehi A, Delcroix JD, Howe CL, Belichenko PV, Chua-Couzens J, Kilbridge JF, Carlson EJ, Epstein CJ, Mobley WC. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proceedings of the National Academy of Sciences of the United States of America. 98: 10439-44. PMID 11504920 DOI: 10.1073/Pnas.181219298 |
0.763 |
|
| 2001 |
Wu C, Lai CF, Mobley WC. Nerve growth factor activates persistent Rap1 signaling in endosomes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 5406-16. PMID 11466412 DOI: 10.1523/Jneurosci.21-15-05406.2001 |
0.344 |
|
| 2001 |
Cooper JD, Mobley WC. Neurotrophic factors as potential therapeutic agents in neuronal ceroid lipofuscinosis. Advances in Genetics. 45: 169-82. PMID 11332772 DOI: 10.1016/S0065-2660(01)45010-3 |
0.452 |
|
| 2001 |
Mischel PS, Smith SG, Vining ER, Valletta JS, Mobley WC, Reichardt LF. The extracellular domain of p75NTR is necessary to inhibit neurotrophin-3 signaling through TrkA. The Journal of Biological Chemistry. 276: 11294-301. PMID 11150291 DOI: 10.1074/Jbc.M005132200 |
0.329 |
|
| 2000 |
Lynch C, Mobley W. Comprehensive theory of Alzheimer's disease. The effects of cholesterol on membrane receptor trafficking Annals of the New York Academy of Sciences. 924: 104-111. PMID 11193786 DOI: 10.1111/J.1749-6632.2000.Tb05568.X |
0.38 |
|
| 2000 |
Beattie EC, Howe CL, Wilde A, Brodsky FM, Mobley WC. NGF signals through TrkA to increase clathrin at the plasma membrane and enhance clathrin-mediated membrane trafficking. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 7325-33. PMID 11007890 DOI: 10.1523/Jneurosci.20-19-07325.2000 |
0.611 |
|
| 2000 |
Villoslada P, Hauser SL, Bartke I, Unger J, Heald N, Rosenberg D, Cheung SW, Mobley WC, Fisher S, Genain CP. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. The Journal of Experimental Medicine. 191: 1799-806. PMID 10811872 DOI: 10.1084/Jem.191.10.1799 |
0.356 |
|
| 2000 |
Salehi A, Cooper JD, Alonso MA, Swaab DF, Mobley WC. Neurotrophin receptors in Alzheimer brain and A mouse model of down syndrome Neurobiology of Aging. 21: 114. DOI: 10.1016/S0197-4580(00)82310-6 |
0.678 |
|
| 1999 |
Huang CS, Zhou J, Feng AK, Lynch CC, Klumperman J, DeArmond SJ, Mobley WC. Nerve growth factor signaling in caveolae-like domains at the plasma membrane. The Journal of Biological Chemistry. 274: 36707-14. PMID 10593976 DOI: 10.1074/Jbc.274.51.36707 |
0.37 |
|
| 1999 |
Mitchison HM, Bernard DJ, Greene ND, Cooper JD, Junaid MA, Pullarkat RK, de Vos N, Breuning MH, Owens JW, Mobley WC, Gardiner RM, Lake BD, Taschner PE, Nussbaum RL. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]. Neurobiology of Disease. 6: 321-34. PMID 10527801 DOI: 10.1006/Nbdi.1999.0267 |
0.348 |
|
| 1999 |
Yuen EC, Mobley WC. Early BDNF, NT-3, and NT-4 signaling events. Experimental Neurology. 159: 297-308. PMID 10486198 DOI: 10.1006/Exnr.1999.7148 |
0.352 |
|
| 1999 |
Cooper JD, Messer A, Feng AK, Chua-Couzens J, Mobley WC. Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2556-67. PMID 10087069 DOI: 10.1523/Jneurosci.19-07-02556.1999 |
0.401 |
|
| 1999 |
Cooper JD, Mobley WC. Pathologic Involvement of Interneurons in Mouse Models of Neuronal Ceroid Lipofuscinosis Pediatric Research. 45: 340A-340A. DOI: 10.1203/00006450-199904020-02021 |
0.358 |
|
| 1998 |
Butte MJ, Hwang PK, Mobley WC, Fletterick RJ. Crystal structure of neurotrophin-3 homodimer shows distinct regions are used to bind its receptors. Biochemistry. 37: 16846-52. PMID 9836577 DOI: 10.1021/Bi981254O |
0.313 |
|
| 1998 |
Fagan AM, Murphy BA, Patel SN, Kilbridge JF, Mobley WC, Bu G, Holtzman DM. Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury. Experimental Neurology. 151: 314-25. PMID 9628766 DOI: 10.1006/Exnr.1998.6818 |
0.519 |
|
| 1998 |
Sago H, Carlson EJ, Smith DJ, Kilbridge J, Rubin EM, Mobley WC, Epstein CJ, Huang TT. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proceedings of the National Academy of Sciences of the United States of America. 95: 6256-61. PMID 9600952 DOI: 10.1073/Pnas.95.11.6256 |
0.31 |
|
| 1997 |
Schätzl HM, Laszlo L, Holtzman DM, Tatzelt J, DeArmond SJ, Weiner RI, Mobley WC, Prusiner SB. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. Journal of Virology. 71: 8821-31. PMID 9343242 DOI: 10.1128/Jvi.71.11.8821-8831.1997 |
0.485 |
|
| 1997 |
Yeo TT, Chua-Couzens J, Butcher LL, Bredesen DE, Cooper JD, Valletta JS, Mobley WC, Longo FM. Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 7594-605. PMID 9315882 DOI: 10.1523/Jneurosci.17-20-07594.1997 |
0.4 |
|
| 1997 |
Grimes ML, Beattie E, Mobley WC. A signaling organelle containing the nerve growth factor-activated receptor tyrosine kinase, TrkA. Proceedings of the National Academy of Sciences of the United States of America. 94: 9909-14. PMID 9275225 DOI: 10.1073/Pnas.94.18.9909 |
0.419 |
|
| 1996 |
Beattie EC, Zhou J, Grimes ML, Bunnett NW, Howe CL, Mobley WC. A signaling endosome hypothesis to explain NGF actions: potential implications for neurodegeneration. Cold Spring Harbor Symposia On Quantitative Biology. 61: 389-406. PMID 9246468 DOI: 10.1101/Sqb.1996.061.01.042 |
0.61 |
|
| 1996 |
Grimes ML, Zhou J, Beattie EC, Yuen EC, Hall DE, Valletta JS, Topp KS, LaVail JH, Bunnett NW, Mobley WC. Endocytosis of activated TrkA: evidence that nerve growth factor induces formation of signaling endosomes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 7950-64. PMID 8987823 DOI: 10.1523/Jneurosci.16-24-07950.1996 |
0.412 |
|
| 1996 |
Holtzman DM, Santucci D, Kilbridge J, Chua-Couzens J, Fontana DJ, Daniels SE, Johnson RM, Chen K, Sun Y, Carlson E, Alleva E, Epstein CJ, Mobley WC. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proceedings of the National Academy of Sciences of the United States of America. 93: 13333-8. PMID 8917591 DOI: 10.1073/Pnas.93.23.13333 |
0.515 |
|
| 1996 |
Yuen EC, Howe CL, Li Y, Holtzman DM, Mobley WC. Nerve growth factor and the neurotrophic factor hypothesis. Brain & Development. 18: 362-8. PMID 8891230 DOI: 10.1016/0387-7604(96)00051-4 |
0.692 |
|
| 1996 |
Holtzman DM, Lee S, Li Y, Chua-Couzens J, Xia H, Bredt DS, Mobley WC. Expression of neuronal-NOS in developing basal forebrain cholinergic neurons: regulation by NGF. Neurochemical Research. 21: 861-8. PMID 8873091 DOI: 10.1007/Bf02532310 |
0.516 |
|
| 1996 |
Neve RL, Valletta JS, Li Y, Ventosa-Michelman M, Holtzman DM, Mobley WC. A comprehensive study of the spatiotemporal pattern of beta-amyloid precursor protein mRNA and protein in the rat brain: lack of modulation by exogenously applied nerve growth factor. Brain Research. Molecular Brain Research. 39: 185-97. PMID 8804727 DOI: 10.1016/0169-328X(96)00007-1 |
0.468 |
|
| 1996 |
Mobley WC. 340 Neurotrophin signalling: Implications for neurodegeneration Neurobiology of Aging. 17: S85. DOI: 10.1016/S0197-4580(96)80342-3 |
0.313 |
|
| 1996 |
Holtzman DM, Epstein CJ, Mobley WC. The human trisomy 21 brain: Insights from mouse models of Down syndrome Mental Retardation and Developmental Disabilities Research Reviews. 2: 66-72. DOI: 10.1002/(Sici)1098-2779(1996)2:2<66::Aid-Mrdd2>3.0.Co;2-V |
0.493 |
|
| 1995 |
Yuen EC, Mobley WC. Therapeutic applications of neurotrophic factors in disorders of motor neurons and peripheral nerves. Molecular Medicine Today. 1: 278-86. PMID 9415162 DOI: 10.1016/S1357-4310(95)91189-8 |
0.355 |
|
| 1995 |
Holtzman DM, Kilbridge J, Chen KS, Rabin J, Luche R, Carlson E, Epstein CJ, Mobley WC. Preliminary characterization of the central nervous system in partial trisomy 16 mice. Progress in Clinical and Biological Research. 393: 227-40. PMID 8545453 |
0.368 |
|
| 1995 |
Holtzman DM, Kilbridge J, Li Y, Cunningham ET, Lenn NJ, Clary DO, Reichardt LF, Mobley WC. TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 1567-76. PMID 7869118 DOI: 10.1523/Jneurosci.15-02-01567.1995 |
0.534 |
|
| 1995 |
Zhou J, Valletta JS, Grimes ML, Mobley WC. Multiple levels for regulation of TrkA in PC12 cells by nerve growth factor. Journal of Neurochemistry. 65: 1146-56. PMID 7543930 DOI: 10.1046/J.1471-4159.1995.65031146.X |
0.398 |
|
| 1995 |
Li Y, Holtzman DM, Kromer LF, Kaplan DR, Chua-Couzens J, Clary DO, Knüsel B, Mobley WC. Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 2888-905. PMID 7536822 DOI: 10.1523/Jneurosci.15-04-02888.1995 |
0.533 |
|
| 1994 |
Holtzman DM, Kilbridge J, Bredt DS, Black SM, Li Y, Clary DO, Reichardt LF, Mobley WC. NOS induction by NGF in basal forebrain cholinergic neurones: evidence for regulation of brain NOS by a neurotrophin. Neurobiology of Disease. 1: 51-60. PMID 9216986 DOI: 10.1006/Nbdi.1994.0007 |
0.529 |
|
| 1994 |
Zhou J, Holtzman DM, Weiner RI, Mobley WC. Expression of TrkA confers neuron-like responsiveness to nerve growth factor on an immortalized hypothalamic cell line. Proceedings of the National Academy of Sciences of the United States of America. 91: 3824-8. PMID 8170995 DOI: 10.1073/Pnas.91.9.3824 |
0.548 |
|
| 1994 |
Chen CK, Kinsman SL, Holtzman DM, Mobley WC, Johnston MV. A reverse transcription-polymerase chain reaction study of p75 nerve growth factor receptor gene expression in developing rat cerebellum. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 12: 255-62. PMID 7976482 DOI: 10.1016/0736-5748(94)90072-8 |
0.457 |
|
| 1994 |
Holtzman DM, Mobley WC. Neurotrophic factors and neurologic disease. The Western Journal of Medicine. 161: 246-54. PMID 7975562 |
0.446 |
|
| 1994 |
Burke MA, Mobley WC, Cho J, Wiegand SJ, Lindsay RM, Mufson EJ, Kordower JH. Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins. Experimental Neurology. 130: 178-95. PMID 7867749 DOI: 10.1006/Exnr.1994.1197 |
0.412 |
|
| 1994 |
Higgins LS, Holtzman DM, Rabin J, Mobley WC, Cordell B. Transgenic mouse brain histopathology resembles early Alzheimer's disease. Annals of Neurology. 35: 598-607. PMID 7513982 DOI: 10.1002/Ana.410350514 |
0.462 |
|
| 1993 |
Holtzman DM, Li Y, Chen K, Gage FH, Epstein CJ, Mobley WC. Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration. Neurology. 43: 2668-73. PMID 8255474 DOI: 10.1212/Wnl.43.12.2668 |
0.581 |
|
| 1993 |
Sofroniew MV, Mobley WC. On the possibility of positive-feedback in trophic interactions between afferent and target neurons Seminars in Neuroscience. 5: 309-312. DOI: 10.1016/S1044-5765(05)80036-3 |
0.378 |
|
| 1993 |
Grimes M, Zhou J, Li Y, Holtzman D, Mobley WC. Neurotrophin signalling in the nervous system Seminars in Neuroscience. 5: 239-247. DOI: 10.1016/S1044-5765(05)80029-6 |
0.545 |
|
| 1992 |
Holtzman DM, Li YW, DeArmond SJ, McKinley MP, Gage FH, Epstein CJ, Mobley WC. Mouse model of neurodegeneration: atrophy of basal forebrain cholinergic neurons in trisomy 16 transplants. Proceedings of the National Academy of Sciences of the United States of America. 89: 1383-7. PMID 1741393 DOI: 10.1073/Pnas.89.4.1383 |
0.542 |
|
| 1992 |
Holtzman DM, Li Y, Parada LF, Kinsman S, Chen CK, Valletta JS, Zhou J, Long JB, Mobley WC. p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF. Neuron. 9: 465-78. PMID 1524827 DOI: 10.1016/0896-6273(92)90184-F |
0.547 |
|
| 1992 |
Holtzman DM, Li Y, Gage FH, Epstein CJ, Mobley WC. Neurodegeneration and gene dysregulation: studies utilizing the mouse trisomy 16 model of Down syndrome. Progress in Clinical and Biological Research. 379: 227-44. PMID 1409747 |
0.389 |
|
| 1992 |
Holtzman DM, Bayney RM, Li YW, Khosrovi H, Berger CN, Epstein CJ, Mobley WC. Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome. The Embo Journal. 11: 619-27. PMID 1371464 DOI: 10.1002/J.1460-2075.1992.Tb05094.X |
0.449 |
|
| 1991 |
Koliatsos VE, Applegate MD, Knüsel B, Junard EO, Burton LE, Mobley WC, Hefti FF, Price DL. Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat. Experimental Neurology. 112: 161-73. PMID 2037030 DOI: 10.1016/0014-4886(91)90066-L |
0.42 |
|
| 1991 |
Fahnestock M, Woo JE, Lopez GA, Snow J, Walz DA, Arici MJ, Mobley WC. beta-NGF-endopeptidase: structure and activity of a kallikrein encoded by the gene mGK-22. Biochemistry. 30: 3443-50. PMID 2012805 DOI: 10.1021/Bi00228A014 |
0.326 |
|
| 1991 |
Gold BG, Mobley WC, Matheson SF. Regulation of axonal caliber, neurofilament content, and nuclear localization in mature sensory neurons by nerve growth factor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 943-55. PMID 2010817 DOI: 10.1523/Jneurosci.11-04-00943.1991 |
0.372 |
|
| 1991 |
Holtzman DM, Mobley WC. Molecular studies in Alzheimer's disease. Trends in Biochemical Sciences. 16: 140-4. PMID 1877089 DOI: 10.1016/0968-0004(91)90056-2 |
0.448 |
|
| 1991 |
Koliatsos VE, Shelton DL, Mobley WC, Price DL. A novel group of nerve growth factor receptor-immunoreactive neurons in the ventral horn of the lumbar spinal cord. Brain Research. 541: 121-8. PMID 1851446 DOI: 10.1016/0006-8993(91)91084-E |
0.352 |
|
| 1991 |
Holtzman DM, Li YW, Gage FH, DeArmond SJ, Epstein CJ, McKinley MP, Mobley WC. Modeling cholinergic abnormalities in Down syndrome and Alzheimer's disease. Progress in Clinical and Biological Research. 373: 189-202. PMID 1838184 |
0.413 |
|
| 1991 |
Koliatsos VE, Clatterbuck RE, Nauta HJ, Knüsel B, Burton LE, Hefti FF, Mobley WC, Price DL. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Annals of Neurology. 30: 831-40. PMID 1789695 DOI: 10.1002/Ana.410300613 |
0.435 |
|
| 1991 |
Taiwo YO, Levine JD, Burch RM, Woo JE, Mobley WC. Hyperalgesia induced in the rat by the amino-terminal octapeptide of nerve growth factor. Proceedings of the National Academy of Sciences of the United States of America. 88: 5144-8. PMID 1647026 DOI: 10.1073/Pnas.88.12.5144 |
0.378 |
|
| 1990 |
Koliatsos VE, Nauta HJ, Clatterbuck RE, Holtzman DM, Mobley WC, Price DL. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 3801-13. PMID 2269884 DOI: 10.1523/Jneurosci.10-12-03801.1990 |
0.547 |
|
| 1990 |
Knüsel B, Burton LE, Longo FM, Mobley WC, Koliatsos VE, Price DL, Hefti F. Trophic actions of recombinant human nerve growth factor on cultured rat embryonic CNS cells. Experimental Neurology. 110: 274-83. PMID 2249737 DOI: 10.1016/0014-4886(90)90039-U |
0.388 |
|
| 1990 |
Longo FM, Vu TK, Mobley WC. The in vitro biological effect of nerve growth factor is inhibited by synthetic peptides. Cell Regulation. 1: 189-95. PMID 2100197 DOI: 10.1091/Mbc.1.2.189 |
0.37 |
|
| 1990 |
McKinley MP, Longo FM, Valletta JS, Rahbar F, Neve RL, Prusiner SB, Mobley WC. Nerve growth factor induces gene expression of the prion protein and beta-amyloid protein precursor in the developing hamster central nervous system. Progress in Brain Research. 86: 227-38. PMID 1982367 DOI: 10.1016/S0079-6123(08)63180-5 |
0.418 |
|
| 1989 |
Mobley WC. Nerve growth factor in Alzheimer's disease: to treat or not to treat? Neurobiology of Aging. 10: 578-80; discussion 5. PMID 2812231 DOI: 10.1016/0197-4580(89)90135-8 |
0.399 |
|
| 1989 |
Saffran BN, Woo JE, Mobley WC, Crutcher KA. Intraventricular NGF infusion in the mature rat brain enhances sympathetic innervation of cerebrovascular targets but fails to elicit sympathetic ingrowth. Brain Research. 492: 245-54. PMID 2752299 DOI: 10.1016/0006-8993(89)90907-4 |
0.389 |
|
| 1989 |
Hsiang J, Heller A, Hoffmann PC, Mobley WC, Wainer BH. The effects of nerve growth factor on the development of septal cholinergic neurons in reaggregate cell cultures. Neuroscience. 29: 209-23. PMID 2710345 DOI: 10.1016/0306-4522(89)90344-8 |
0.38 |
|
| 1989 |
Phelps CH, Gage FH, Growdon JH, Hefti F, Harbaugh R, Johnston MV, Khachaturian ZS, Mobley WC, Price DL, Raskind M. Potential use of nerve growth factor to treat Alzheimer's disease. Neurobiology of Aging. 10: 205-7. PMID 2657468 DOI: 10.1016/0197-4580(89)90032-8 |
0.337 |
|
| 1989 |
Mobley WC, Woo JE, Edwards RH, Riopelle RJ, Longo FM, Weskamp G, Otten U, Valletta JS, Johnston MV. Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen. Neuron. 3: 655-64. PMID 2561975 DOI: 10.1016/0896-6273(89)90276-6 |
0.419 |
|
| 1989 |
McKinley MP, DeArmond SJ, Torchia M, Mobley WC, Prusiner SB. Acceleration of scrapie in neonatal Syrian hamsters. Neurology. 39: 1319-24. PMID 2507957 DOI: 10.1212/Wnl.39.10.1319 |
0.327 |
|
| 1988 |
Edwards RH, Selby MJ, Mobley WC, Weinrich SL, Hruby DE, Rutter WJ. Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia virus vector. Molecular and Cellular Biology. 8: 2456-64. PMID 3405211 DOI: 10.1128/Mcb.8.6.2456 |
0.355 |
|
| 1988 |
Mobley WC, Neve RL, Prusiner SB, McKinley MP. Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain. Proceedings of the National Academy of Sciences of the United States of America. 85: 9811-5. PMID 2904679 DOI: 10.1073/Pnas.85.24.9811 |
0.372 |
|
| 1987 |
Johnston MV, Rutkowski JL, Wainer BH, Long JB, Mobley WC. NGF effects on developing forebrain cholinergic neurons are regionally specific. Neurochemical Research. 12: 985-94. PMID 3683745 DOI: 10.1007/Bf00970927 |
0.407 |
|
| 1986 |
Mobley WC, Rutkowski JL, Tennekoon GI, Gemski J, Buchanan K, Johnston MV. Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Brain Research. 387: 53-62. PMID 3742234 DOI: 10.1016/0169-328X(86)90020-3 |
0.418 |
|
| 1985 |
Kitt CA, Struble RG, Cork LC, Mobley WC, Walker LC, Joh TH, Price DL. Catecholaminergic neurites in senile plaques in prefrontal cortex of aged nonhuman primates. Neuroscience. 16: 691-9. PMID 2869445 DOI: 10.1016/0306-4522(85)90202-7 |
0.307 |
|
| 1985 |
Mobley WC, Rutkowski JL, Tennekoon GI, Buchanan K, Johnston MV. Choline acetyltransferase activity in striatum of neonatal rats increased by nerve growth factor. Science (New York, N.Y.). 229: 284-7. PMID 2861660 DOI: 10.1126/Science.2861660 |
0.407 |
|
| 1984 |
Kitt CA, Price DL, Struble RG, Cork LC, Wainer BH, Becher MW, Mobley WC. Evidence for cholinergic neurites in senile plaques. Science (New York, N.Y.). 226: 1443-5. PMID 6505701 DOI: 10.1126/Science.6505701 |
0.329 |
|
| 1977 |
Mobley WC, Server AC, Ishii DN, Riopelle RJ, Shooter EM. Nerve growth factor (third of three parts). The New England Journal of Medicine. 297: 1211-8. PMID 411033 DOI: 10.1056/Nejm197712012972205 |
0.534 |
|
| 1977 |
Mobley WC, Server AC, Ishii DN, Riopelle RJ, Shooter EM. Nerve growth factor (first of three parts). The New England Journal of Medicine. 297: 1096-104. PMID 333290 DOI: 10.1056/Nejm197711172972005 |
0.534 |
|
| 1977 |
Mobley WC, Server AC, Ishii DN, Riopelle RJ, Shooter EM. Nerve growth factor (second of three parts). The New England Journal of Medicine. 297: 1149-58. PMID 72356 DOI: 10.1056/NEJM197711242972105 |
0.479 |
|
| 1976 |
Mobley WC, Schenker A, Shooter EM. Characterization and isolation of proteolytically modified nerve growth factor. Biochemistry. 15: 5543-52. PMID 999827 DOI: 10.1021/Bi00670A019 |
0.532 |
|
| 1975 |
Bjerre B, Björklund A, Mobley W, Rosengren E. Short- and long-term effects of nerve growth factor on the sympathetic nervous system in the adult mouse. Brain Research. 94: 263-77. PMID 1148872 DOI: 10.1016/0006-8993(75)90061-X |
0.381 |
|
| 1974 |
Moore JB, Mobley WC, Shooter EM. Proteolytic modification of the beta nerve growth factor protein. Biochemistry. 13: 833-40. PMID 4811070 DOI: 10.1021/Bi00701A030 |
0.523 |
|
| 1974 |
Bjerre B, Björklund A, Mobley W. A stimulatory effect by nerve growth factor on the regrowth of adrenergic nerve fibres in the mouse peripheral tissues after chemical sympathectomy with 6-hydroxydopamine. Zeitschrift Fur Zellforschung Und Mikroskopische Anatomie (Vienna, Austria : 1948). 146: 15-43. PMID 4777497 DOI: 10.1007/Bf00306757 |
0.393 |
|
| 1974 |
Stenevi U, Bjerre B, Björklund A, Mobley W. Effects of localized intracerebral injections of nerve growth factor on the regenerative growth of lesioned central noradrenergic neurones. Brain Research. 69: 217-34. PMID 4406332 DOI: 10.1016/0006-8993(74)90003-1 |
0.392 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2016 |
Xing Z, Li Y, Pao A, Bennett AS, Tycko B, Mobley WC, Yu YE. Mouse-based genetic modeling and analysis of Down syndrome. British Medical Bulletin. PMID 27789459 DOI: 10.1093/Bmb/Ldw040 |
0.298 |
|
| 1989 |
Sharp FR, Gonzalez MF, Hisanaga K, Mobley WC, Sagar SM. Induction of the c-fos gene product in rat forebrain following cortical lesions and NGF injections. Neuroscience Letters. 100: 117-22. PMID 2503789 DOI: 10.1016/0304-3940(89)90670-8 |
0.294 |
|
| 1998 |
Tremblay P, Meiner Z, Galou M, Heinrich C, Petromilli C, Lisse T, Cayetano J, Torchia M, Mobley W, Bujard H, DeArmond SJ, Prusiner SB. Doxycycline control of prion protein transgene expression modulates prion disease in mice. Proceedings of the National Academy of Sciences of the United States of America. 95: 12580-5. PMID 9770528 DOI: 10.1073/Pnas.95.21.12580 |
0.293 |
|
| 2009 |
Mégarbané A, Ravel A, Mircher C, Sturtz F, Grattau Y, Rethoré MO, Delabar JM, Mobley WC. The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 11: 611-6. PMID 19636252 DOI: 10.1097/Gim.0B013E3181B2E34C |
0.29 |
|
| 2005 |
Belichenko PV, Dickson PI, Passage M, Jungles S, Mobley WC, Kakkis ED. Penetration, diffusion, and uptake of recombinant human alpha-L-iduronidase after intraventricular injection into the rat brain. Molecular Genetics and Metabolism. 86: 141-9. PMID 16006167 DOI: 10.1016/J.Ymgme.2005.04.013 |
0.289 |
|
| 2023 |
Moya-Alvarado G, Tiburcio-Felix R, Ibáñez MR, Aguirre-Soto AA, Guerra MV, Wu C, Mobley WC, Perlson E, Bronfman FC. BDNF/TrkB signaling endosomes in axons coordinate CREB/mTOR activation and protein synthesis in the cell body to induce dendritic growth in cortical neurons. Elife. 12. PMID 36826992 DOI: 10.7554/eLife.77455 |
0.286 |
|
| 1996 |
DeArmond SJ, Qiu Y, Wong K, Nixon R, Hyun W, Prusiner SB, Mobley WC. Abnormal plasma membrane properties and functions in prion-infected cell lines. Cold Spring Harbor Symposia On Quantitative Biology. 61: 531-40. PMID 9246479 DOI: 10.1101/Sqb.1996.061.01.053 |
0.285 |
|
| 1987 |
DeArmond SJ, Mobley WC, DeMott DL, Barry RA, Beckstead JH, Prusiner SB. Changes in the localization of brain prion proteins during scrapie infection. Neurology. 37: 1271-80. PMID 3112607 DOI: 10.1212/Wnl.37.8.1271 |
0.285 |
|
| 2014 |
Wagner SL, Zhang C, Cheng S, Nguyen P, Zhang X, Rynearson KD, Wang R, Li Y, Sisodia SS, Mobley WC, Tanzi RE. Soluble γ-secretase modulators selectively inhibit the production of the 42-amino acid amyloid β peptide variant and augment the production of multiple carboxy-truncated amyloid β species. Biochemistry. 53: 702-13. PMID 24401146 DOI: 10.1021/Bi401537V |
0.284 |
|
| 2010 |
Zhang H, Petit G, Gaughwin PM, Zuo X, Ranganathan S, Smith R, Roybon L, Brundin P, Mobley WC, Li J. B16 NGF improves the spatial working memory in R6/1 Huntington's disease transgenic mice through the augmentation of cholinergic function and neurogenesis Journal of Neurology, Neurosurgery & Psychiatry. 81: A16.4-A16. DOI: 10.1136/Jnnp.2010.222596.16 |
0.283 |
|
| 1980 |
Asbury A, Fisher R, McKhann GM, Mobley W, Server A. Guillain-Barré syndrome: is there a role for plasmapheresis? Neurology. 30: 1112-1112. PMID 7191502 DOI: 10.1212/Wnl.30.10.1112 |
0.281 |
|
| 1990 |
Burgin KE, Waxham MN, Rickling S, Westgate SA, Mobley WC, Kelly PT. In situ hybridization histochemistry of Ca2+/calmodulin-dependent protein kinase in developing rat brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 1788-98. PMID 2162385 DOI: 10.1523/Jneurosci.10-06-01788.1990 |
0.281 |
|
| 2020 |
Rynearson KD, Buckle RN, Herr RJ, Mayhew NJ, Chen X, Paquette WD, Sakwa SA, Yang J, Barnes KD, Nguyen P, Mobley WC, Johnson G, Lin JH, Tanzi RE, Wagner SL. Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators. Bioorganic & Medicinal Chemistry. 28: 115734. PMID 33007551 DOI: 10.1016/J.Bmc.2020.115734 |
0.278 |
|
| 2004 |
Kakkis E, McEntee M, Vogler C, Le S, Levy B, Belichenko P, Mobley W, Dickson P, Hanson S, Passage M. Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I Molecular Genetics and Metabolism. 83: 163-174. PMID 15464431 DOI: 10.1016/J.Ymgme.2004.07.003 |
0.275 |
|
| 2013 |
Trzoss L, Xu J, Lacoske MH, Mobley WC, Theodorakis EA. Illicium sesquiterpenes: divergent synthetic strategy and neurotrophic activity studies. Chemistry (Weinheim An Der Bergstrasse, Germany). 19: 6398-408. PMID 23526661 DOI: 10.1002/Chem.201300198 |
0.275 |
|
| 2024 |
Gu Y, Pope A, Smith C, Carmona C, Johnstone A, Shi L, Chen X, Santos S, Bacon-Brenes CC, Shoff T, Kleczko KM, Frydman J, Thompson LM, Mobley WC, Wu C. BDNF and TRiC-inspired reagent rescue cortical synaptic deficits in a mouse model of Huntington's disease. Neurobiology of Disease. 106502. PMID 38608784 DOI: 10.1016/j.nbd.2024.106502 |
0.272 |
|
| 2016 |
Peiris H, Duffield MD, Fadista J, Jessup CF, Kashmir V, Genders AJ, McGee SL, Martin AM, Saiedi M, Morton N, Carter R, Cousin MA, Kokotos AC, Oskolkov N, Volkov P, ... ... Mobley WC, et al. A Syntenic Cross Species Aneuploidy Genetic Screen Links RCAN1 Expression to β-Cell Mitochondrial Dysfunction in Type 2 Diabetes. Plos Genetics. 12: e1006033. PMID 27195491 DOI: 10.1371/Journal.Pgen.1006033 |
0.271 |
|
| 2010 |
Kleschevnikov A, Belichenko P, Mobley W. [S1.3]: Reversing learning and memory deficits in a mouse model of Down syndrome International Journal of Developmental Neuroscience. 28: 643-643. DOI: 10.1016/J.Ijdevneu.2010.07.011 |
0.269 |
|
| 2010 |
Shamloo M, Belichenko PV, Mobley WC. Comprehensive behavioral assays to enhance phenotype to genotype linkages and therapeutic screening in mouse models of down syndrome Future Neurology. 5: 467-471. DOI: 10.2217/Fnl.10.29 |
0.269 |
|
| 2012 |
Wagner SL, Tanzi RE, Mobley WC, Galasko D. Potential use of γ-secretase modulators in the treatment of Alzheimer disease. Archives of Neurology. 69: 1255-8. PMID 22801784 DOI: 10.1001/Archneurol.2012.540 |
0.269 |
|
| 1999 |
Wilde A, Beattie EC, Lem L, Riethof DA, Liu SH, Mobley WC, Soriano P, Brodsky FM. EGF receptor signaling stimulates SRC kinase phosphorylation of clathrin, influencing clathrin redistribution and EGF uptake. Cell. 96: 677-87. PMID 10089883 DOI: 10.1016/S0092-8674(00)80578-4 |
0.265 |
|
| 2020 |
Herault Y, Mobley W, Haydar T. Decision letter: A non-mosaic transchromosomic mouse model of Down syndrome carrying the long arm of human chromosome 21 Elife. DOI: 10.7554/Elife.56223.Sa1 |
0.265 |
|
| 2015 |
Do LH, Mobley WC, Singhal N. Questioned validity of Gene Expression Dysregulated Domains in Down's Syndrome. F1000research. 4: 269. PMID 26664707 DOI: 10.12688/F1000Research.6735.1 |
0.264 |
|
| 2013 |
Mobley W. F3-01-01: Exploring the pathogenesis of cognitive impairment in Down syndrome: Genes, mechanisms and treatment targets Alzheimer's & Dementia. 9: P513-P513. DOI: 10.1016/J.Jalz.2013.04.222 |
0.263 |
|
| 1996 |
Yuen EC, Mobley WC. Therapeutic potential of neurotrophic factors for neurological disorders. Annals of Neurology. 40: 346-54. PMID 8797524 DOI: 10.1002/Ana.410400304 |
0.262 |
|
| 2005 |
Gardiner K, Davisson MT, Pritchard M, Patterson D, Groner Y, Crnic LS, Antonarakis S, Mobley W. Report on the 'Expert Workshop on the Biology of Chromosome 21: Towards gene-phenotype correlations in Down syndrome', held June 11-14, 2004, Washington D.C Cytogenetic and Genome Research. 108: 269-277. PMID 15627744 DOI: 10.1159/000081518 |
0.256 |
|
| 2011 |
Trzoss L, Xu J, Lacoske MH, Mobley WC, Theodorakis EA. Enantioselective synthesis of (-)-jiadifenin, a potent neurotrophic modulator. Organic Letters. 13: 4554-7. PMID 21812392 DOI: 10.1021/Ol201742J |
0.251 |
|
| 2021 |
Chen XQ, Das U, Park G, Mobley WC. Normal levels of KIF5 but reduced KLC1 levels in both Alzheimer disease and Alzheimer disease in Down syndrome: evidence suggesting defects in anterograde transport. Alzheimer's Research & Therapy. 13: 59. PMID 33691783 DOI: 10.1186/s13195-021-00796-6 |
0.251 |
|
| 2020 |
Ho D, Quake SR, McCabe ERB, Chng WJ, Chow EK, Ding X, Gelb BD, Ginsburg GS, Hassenstab J, Ho CM, Mobley WC, Nolan GP, Rosen ST, Tan P, Yen Y, et al. Enabling Technologies for Personalized and Precision Medicine. Trends in Biotechnology. PMID 31980301 DOI: 10.1016/J.Tibtech.2019.12.021 |
0.246 |
|
| 2008 |
Chial HJ, Wu R, Ustach CV, McPhail LC, Mobley WC, Chen YQ. Membrane targeting by APPL1 and APPL2: dynamic scaffolds that oligomerize and bind phosphoinositides. Traffic (Copenhagen, Denmark). 9: 215-29. PMID 18034774 DOI: 10.1111/J.1600-0854.2007.00680.X |
0.241 |
|
| 1996 |
Mobley WC. Recent progress in developmental neurology: exploring the bench to bedside interface. Current Opinion in Neurology. 9: 107-112. PMID 8782977 DOI: 10.1097/00019052-199604000-00009 |
0.239 |
|
| 2022 |
Chen XQ, Zuo X, Becker A, Head E, Mobley WC. Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36370135 DOI: 10.1002/alz.12835 |
0.236 |
|
| 2023 |
Fu XD, Mobley WC. Therapeutic Potential of PTB Inhibition Through Converting Glial Cells to Neurons in the Brain. Annual Review of Neuroscience. 46: 145-165. PMID 37428606 DOI: 10.1146/annurev-neuro-083022-113120 |
0.235 |
|
| 2013 |
Devor A, Bandettini PA, Boas DA, Bower JM, Buxton RB, Cohen LB, Dale AM, Einevoll GT, Fox PT, Franceschini MA, Friston KJ, Fujimoto JG, Geyer MA, Greenberg JH, Halgren E, ... ... Mobley WC, et al. The challenge of connecting the dots in the B.R.A.I.N. Neuron. 80: 270-4. PMID 24139032 DOI: 10.1016/J.Neuron.2013.09.008 |
0.235 |
|
| 1978 |
Shapira R, Mobley WC, Thiele SB, Wilhelmi MR, Wallace A, Kibler RF. Localization of 2',3'-cyclic nucleotide-3'-phosphohydrolase of rabbit brain by sedimentation in a continuous sucrose gradient. Journal of Neurochemistry. 30: 735-44. PMID 206668 DOI: 10.1111/J.1471-4159.1978.Tb10779.X |
0.235 |
|
| 2012 |
Mobley W, Rosenberg RN. The evolution of academic neurology: New information will bring new meaning Archives of Neurology. 69: 308-314. PMID 22083800 DOI: 10.1001/Archneurol.2011.1858 |
0.232 |
|
| 2024 |
de Luzy IR, Lee MK, Mobley WC, Studer L. Lessons from inducible pluripotent stem cell models on neuronal senescence in aging and neurodegeneration. Nature Aging. PMID 38429379 DOI: 10.1038/s43587-024-00586-3 |
0.229 |
|
| 2008 |
Eaton DL, Daroff RB, Autrup H, Bridges J, Buffler P, Costa LG, Coyle J, McKhann G, Mobley WC, Nadel L, Neubert D, Schulte-Hermann R, Spencer PS. Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment. Critical Reviews in Toxicology. 38: 1-125. PMID 18726789 DOI: 10.1080/10408440802272158 |
0.223 |
|
| 2008 |
Colas D, Valletta JS, Takimoto-Kimura R, Nishino S, Fujiki N, Mobley WC, Mignot E. Sleep and EEG features in genetic models of Down syndrome. Neurobiology of Disease. 30: 1-7. PMID 18282758 DOI: 10.1016/J.Nbd.2007.07.014 |
0.219 |
|
| 2019 |
Mobley W. Effects of changing development patterns and ignition locations within Central Texas. Plos One. 14: e0211454. PMID 30730903 DOI: 10.1371/Journal.Pone.0211454 |
0.217 |
|
| 1997 |
Yeo TT, Chua-Couzens J, Butcher LL, Bredesen DE, Cooper JD, Valletta JS, Mobley WC, Longo FM. Absence of p75NTRCauses Increased Basal Forebrain Cholinergic Neuron Size, Choline Acetyltransferase Activity, and Target Innervation The Journal of Neuroscience. 17: 7594-7605. DOI: 10.1523/JNEUROSCI.17-20-07594.1997 |
0.216 |
|
| 2023 |
Wu GH, Smith-Geater C, Galaz-Montoya JG, Gu Y, Gupte SR, Aviner R, Mitchell PG, Hsu J, Miramontes R, Wang KQ, Geller NR, Hou C, Danita C, Joubert LM, Schmid MF, ... ... Mobley W, et al. CryoET reveals organelle phenotypes in huntington disease patient iPSC-derived and mouse primary neurons. Nature Communications. 14: 692. PMID 36754966 DOI: 10.1038/s41467-023-36096-w |
0.214 |
|
| 1993 |
Gold BG, Storm-Dickerman T, Mobley WC, Austin DR. REGULATION OF TRANSCRIPTION FACTOR C-JUN BY NERVE GROWTH FACTOR IN ADULT SENSORY NEURONS Journal of Neuropathology and Experimental Neurology. 52: 309. DOI: 10.1097/00005072-199305000-00196 |
0.213 |
|
| 1988 |
Gerber WL, de la Pena VE, Mobley WC. Infertility, chemical exposure, and farming in Iowa: absence of an association. Urology. 31: 46-50. PMID 3336927 DOI: 10.1016/0090-4295(88)90571-7 |
0.213 |
|
| 2019 |
Berchum ECv, Mobley W, Jonkman SN, Timmermans JS, Kwakkel JH, Brody SD. Evaluation of flood risk reduction strategies through combinations of interventions Journal of Flood Risk Management. 12. DOI: 10.1111/Jfr3.12506 |
0.211 |
|
| 1988 |
DE ARMQND SJ, GONZALES M, MOBLEY WC, CHARMANI H, PRUSINER SB. BRAIN PRPSC IN HAMSTER IS SPATIALLY AND TEMPORALLY RELATED TO SCRAPIE HISTOPATHOLOGY AND INFECTIVITY TITER Alzheimer Disease & Associated Disorders. 2: 304. DOI: 10.1097/00002093-198802030-00153 |
0.21 |
|
| 2005 |
Greenberg JO, Rizzo M, Mobley WC. An AUPN/ANA survey of department leader opinions on the health of US academic neurology [1] (multiple letters) Neurology. 64: 1664. PMID 15883349 DOI: 10.1212/Wnl.64.9.1664 |
0.21 |
|
| 2020 |
Mobley W, Atoba KO, Highfield WE. Uncertainty in Flood Mitigation Practices: Assessing the Economic Benefits of Property Acquisition and Elevation in Flood-Prone Communities Sustainability. 12: 2098. DOI: 10.3390/Su12052098 |
0.207 |
|
| 2015 |
Do L, Mobley W. Single Figure Publications: Towards a novel alternative format for scholarly communication. F1000research. 4: 268. PMID 27506233 DOI: 10.12688/F1000Research.6742.1 |
0.204 |
|
| 2021 |
Chen XQ, Xing Z, Chen QD, Salvi RJ, Zhang X, Tycko B, Mobley WC, Yu YE. Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome. Frontiers in Aging Neuroscience. 13: 700280. PMID 34276349 DOI: 10.3389/fnagi.2021.700280 |
0.204 |
|
| 1986 |
Mobley WC, Loening SA, Narayana AS, Culp DA. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa. Urology. 27: 335-9. PMID 3083555 DOI: 10.1016/0090-4295(86)90309-2 |
0.202 |
|
| 2023 |
Chen XQ, Sawa M, Becker A, Karachentsev D, Zuo X, Rynearson KD, Tanzi RE, Mobley WC. Retromer proteins reduced in Down syndrome and the Dp16 model: impact of APP dose and preclinical studies of a γ-secretase modulator. Annals of Neurology. PMID 37042072 DOI: 10.1002/ana.26659 |
0.201 |
|
| 2023 |
Overk C, Fiorini E, Babolin C, Vukicevic M, Morici C, Madani R, Eligert V, Kosco-Vilbois M, Roberts A, Becker A, Pfeifer A, Mobley WC. Modeling Alzheimer's disease related phenotypes in the Ts65Dn mouse: impact of age on Aβ, Tau, pTau, NfL, and behavior. Frontiers in Neuroscience. 17: 1202208. PMID 37449271 DOI: 10.3389/fnins.2023.1202208 |
0.201 |
|
| 2018 |
Jiang X, Xiao H, Segal R, Mobley WC, Park H. Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014. Clinical Therapeutics. PMID 29609879 DOI: 10.1016/J.Clinthera.2018.03.006 |
0.194 |
|
| 2021 |
Hendrix JA, Airey DC, Britton A, Burke AD, Capone GT, Chavez R, Chen J, Chicoine B, Costa ACS, Dage JL, Doran E, Esbensen A, Evans CL, Faber KM, Foroud TM, ... ... Mobley W, et al. Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study. Journal of Clinical Medicine. 10. PMID 33924960 DOI: 10.3390/jcm10091907 |
0.194 |
|
| 2019 |
Hendrix J, Burke AD, Capone G, Chicoine B, Costa A, Esbensen AJ, Hart SJ, Head E, Kishnani PS, Lai F, Lott IT, Ochoa-Lubinoff C, Rosas HD, Rosser T, Santoro SL, ... ... Mobley W, et al. P2-030: THE LIFE-DSR STUDY Alzheimer's & Dementia. 15: P582-P583. DOI: 10.1016/J.Jalz.2019.06.1252 |
0.193 |
|
| 2023 |
Hao Y, Hu J, Xue Y, Dowdy SF, Mobley WC, Qian H, Fu XD. Reply to: Ptbp1 deletion does not induce astrocyte-to-neuron conversion. Nature. 618: E8-E13. PMID 37286647 DOI: 10.1038/s41586-023-06067-8 |
0.19 |
|
| 1984 |
Mobley WC, Loening SA, Narayana AS. Combination perineal cryosurgery and external radiation therapy for adenocarcinoma of prostate. Urology. 24: 11-4. PMID 6539996 DOI: 10.1016/0090-4295(84)90377-7 |
0.188 |
|
| 2019 |
Mobley W, Sebastian A, Highfield W, Brody SD. Estimating flood extent during Hurricane Harvey using maximum entropy to build a hazard distribution model Journal of Flood Risk Management. 12. DOI: 10.1111/Jfr3.12549 |
0.188 |
|
| 1996 |
Longo FM, Mobley WC. Minimized hormones grow in stature. Nature Biotechnology. 14: 1092. PMID 9631056 DOI: 10.1038/Nbt0996-1092 |
0.185 |
|
| 2023 |
Valdes P, Henry KW, Fitzgerald MQ, Muralidharan K, Caldwell AB, Ramachandran S, Goldstein LSB, Mobley WC, Galasko DR, Subramaniam S. Limitations of the human iPSC-derived neuron model for early-onset Alzheimer's disease. Molecular Brain. 16: 75. PMID 37924159 DOI: 10.1186/s13041-023-01063-5 |
0.183 |
|
| 2019 |
Ross AD, Rouse SM, Mobley W. Polarization of Climate Change Beliefs: The Role of the Millennial Generation Identity* Social Science Quarterly. 100: 2625-2640. DOI: 10.1111/Ssqu.12640 |
0.182 |
|
| 2022 |
Bartesaghi R, Vicari S, Mobley WC. Prenatal and Postnatal Pharmacotherapy in Down Syndrome: The Search to Prevent or Ameliorate Neurodevelopmental and Neurodegenerative Disorders. Annual Review of Pharmacology and Toxicology. 62: 211-233. PMID 34990205 DOI: 10.1146/annurev-pharmtox-041521-103641 |
0.178 |
|
| 1994 |
Taylor L, Swanson K, Kerigan J, Mobley W, Landreth G. Isolation and characterization of a nerve growth factor-regulated Fos kinase from PC12 cells. Journal of Biological Chemistry. 269: 308-318. DOI: 10.1016/s0021-9258(17)42350-7 |
0.177 |
|
| 2016 |
Matthews DC, Lukic AS, Andrews RD, Marendic B, Brewer J, Rissman RA, Mosconi L, Strother SC, Wernick MN, Mobley WC, Ness S, Schmidt ME, Rafii MS. Dissociation of Down syndrome and Alzheimer's disease effects with imaging Alzheimer's and Dementia: Translational Research and Clinical Interventions. 2: 69-81. DOI: 10.1016/j.trci.2016.02.004 |
0.174 |
|
| 2019 |
Rafii MS, Kleschevnikov AM, Sawa M, Mobley WC. Down syndrome. Handbook of Clinical Neurology. 167: 321-336. PMID 31753140 DOI: 10.1016/B978-0-12-804766-8.00017-0 |
0.17 |
|
| 2011 |
Corbin JG, Paluszkiewicz SM, Martin BS, Huntsman MM, Tranfaglia MR, Liu C, Belichenko PV, Zhang L, Fu D, Kleschevnikov AM, Baldini A, Antonarakis SE, Mobley WC, Yu YE, Chakrabarti L, et al. Author and Subject Index Developmental Neuroscience. 33: 468-468. DOI: 10.1159/000334885 |
0.164 |
|
| 2010 |
Wu C, Mobley WC. Retrograde Neurotrophic Signaling Encyclopedia of Neuroscience. 283-289. DOI: 10.1016/B978-008045046-9.00738-5 |
0.161 |
|
| 2021 |
Rynearson KD, Ponnusamy M, Prikhodko O, Xie Y, Zhang C, Nguyen P, Hug B, Sawa M, Becker A, Spencer B, Florio J, Mante M, Salehi B, Arias C, Galasko D, ... ... Mobley WC, et al. Preclinical validation of a potent γ-secretase modulator for Alzheimer's disease prevention. The Journal of Experimental Medicine. 218. PMID 33651103 DOI: 10.1084/jem.20202560 |
0.155 |
|
| 2013 |
Chao M, Cattaneo A, Mobley W. Rita Levi-Montalcini: the story of an uncommon intellect and spirit. Neuroscience. 252: 431-7. PMID 24288807 DOI: 10.1016/J.Neuroscience.2013.06.055 |
0.149 |
|
| 2021 |
Illouz T, Biragyn A, Frenkel-Morgenstern M, Weissberg O, Gorohovski A, Merzon E, Green I, Iulita F, Flores-Aguilar L, Del Mar Dierssen Sotos M, De Toma I, Lifshitz H, Antonarakis SE, Yu E, Herault Y, ... ... Mobley W, et al. Specific Susceptibility to COVID-19 in Adults with Down Syndrome. Neuromolecular Medicine. PMID 33660221 DOI: 10.1007/s12017-021-08651-5 |
0.148 |
|
| 2020 |
Takahashi T, Sakai N, Iwasaki T, Doyle TC, Mobley WC, Nishino S. Detailed evaluation of the upper airway in the Dp(16)1Yey mouse model of Down syndrome. Scientific Reports. 10: 21323. PMID 33288820 DOI: 10.1038/s41598-020-78278-2 |
0.146 |
|
| 2021 |
Dierssen M, Herault Y, Helguera P, Martínez de Lagran M, Vazquez A, Christian B, Carmona-Iragui M, Wiseman F, Mobley W, Fisher EMC, Brault V, Esbensen A, Jacola LM, Potier MC, Hamlett ED, et al. Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society. Molecular Syndromology. 12: 202-218. PMID 34421499 DOI: 10.1159/000514437 |
0.144 |
|
| 2022 |
Rafii MS, Sol O, Mobley WC, Delpretti S, Skotko BG, Burke AD, Sabbagh MN, Yuan SH, Rissman RA, Pulsifer M, Evans C, Evans AC, Beth G, Fournier N, Gray JA, et al. Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial. Jama Neurology. PMID 35532913 DOI: 10.1001/jamaneurol.2022.0983 |
0.14 |
|
| 1990 |
Sinha S, Dovey HF, Seubert P, Ward PJ, Blacher RW, Blaber M, Bradshaw RA, Arici M, Mobley WC, Lieberburg I. The protease inhibitory properties of the Alzheimer's beta-amyloid precursor protein. The Journal of Biological Chemistry. 265: 8983-5. PMID 2111813 |
0.13 |
|
| 2014 |
Ruparelia A, Mobley WC. Down Syndrome: A Model for Chromosome Abnormalities: A Model for Chromosome Abnormalities Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders. 59-77. DOI: 10.1016/B978-0-12-398270-4.00005-7 |
0.121 |
|
| 2023 |
Johnstone A, Mobley W. Editorial: Current advances in the study of Down Syndrome: From development to aging. Frontiers in Neuroscience. 17: 1161147. PMID 37021132 DOI: 10.3389/fnins.2023.1161147 |
0.116 |
|
| 1988 |
Long JB, Petras JM, Mobley WC, Holaday JW. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function. The Journal of Pharmacology and Experimental Therapeutics. 246: 1167-74. PMID 2901487 |
0.115 |
|
| 2021 |
Illouz T, Biragyn A, Iulita MF, Flores-Aguilar L, Dierssen M, De Toma I, Antonarakis SE, Yu E, Herault Y, Potier MC, Botté A, Roper R, Sredni B, London J, Mobley W, et al. Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome. Frontiers in Immunology. 12: 621440. PMID 34248930 DOI: 10.3389/fimmu.2021.621440 |
0.109 |
|
| 2020 |
Saarma M, Mobley W, Leßmann V. Editorial for the special issue neurotrophic factors. Cell and Tissue Research. 382: 1-4. PMID 32974736 DOI: 10.1007/s00441-020-03291-w |
0.108 |
|
| 2021 |
Illouz T, Biragyn A, Frenkel-Morgenstern M, Weissberg O, Gorohovski A, Merzon E, Green I, Iulita F, Flores-Aguilar L, Dierssen M, De Toma I, Lifshitz H, Antonarakis SE, Yu E, Herault Y, ... ... Mobley W, et al. Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome. Neuromolecular Medicine. PMID 34797469 DOI: 10.1007/s12017-021-08695-7 |
0.104 |
|
| 2021 |
Illouz T, Biragyn A, Frenkel-Morgenstern M, Weissberg O, Gorohovski A, Merzon E, Green I, Iulita F, Flores-Aguilar L, Dierssen M, De Toma I, Lifshitz H, Antonarakis SE, Yu E, Herault Y, ... ... Mobley W, et al. Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome. Neuromolecular Medicine. PMID 33948879 DOI: 10.1007/s12017-021-08657-z |
0.104 |
|
| 2021 |
Santoro SL, Campbell A, Balasubramanian A, Haugen K, Schafer K, Mobley W. Specialty clinics for adults with Down syndrome: A clinic survey. American Journal of Medical Genetics. Part A. 185: 1767-1775. PMID 33729670 DOI: 10.1002/ajmg.a.62169 |
0.093 |
|
| 2021 |
Hendrix JA, Amon A, Abbeduto L, Agiovlasitis S, Alsaied T, Anderson HA, Bain LJ, Baumer N, Bhattacharyya A, Bogunovic D, Botteron KN, Capone G, Chandan P, Chase I, Chicoine B, ... ... Mobley W, et al. Opportunities, barriers, and recommendations in down syndrome research. Translational Science of Rare Diseases. 5: 99-129. PMID 34268067 DOI: 10.3233/trd-200090 |
0.093 |
|
| 2016 |
Bockus AT, Smith LC, Grice AG, Ali OA, Young CC, Mobley W, Leek A, Roberts JL, Vinciguerra B, Isaacs L, Urbach AR. Cucurbit[7]uril-Tetramethylrhodamine Conjugate for Direct Sensing and Cellular Imaging. Journal of the American Chemical Society. 138: 16549-16552. PMID 27998093 DOI: 10.1021/Jacs.6B11140 |
0.089 |
|
| 2015 |
Lee JW, Shin MH, Mobley W, Urbach AR, Kim HI. Supramolecular Enhancement of Protein Analysis via the Recognition of Phenylalanine with Cucurbit[7]uril. Journal of the American Chemical Society. PMID 26565603 DOI: 10.1021/Jacs.5B10648 |
0.074 |
|
| 1982 |
Mobley WC, Wolinsky JS. Scientific overview of inflammatory demyelinating polyneuropathy and design of the North American collaborative study of plasma exchange in Guillain-Barre syndrome. Progress in Clinical and Biological Research. 106: 159-87. PMID 6757937 |
0.07 |
|
| 2002 |
Lo B, Albert MS, Hyman S, Parens E, Wolpe PR, Mobley W. Ethics and the practice of brain science. Cerebrum : the Dana Forum On Brain Science. 4: 64-6. PMID 16619416 |
0.07 |
|
| 1988 |
Long JB, Mobley WC, Holaday JW. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses. The Journal of Pharmacology and Experimental Therapeutics. 246: 1158-66. PMID 2901486 |
0.07 |
|
| 1998 |
DeArmond SJ, Mobley WC, DeMott DL, Barry RA, Beckstead JH, Prusiner SB. Changes in the localization of brain prion proteins during scrapie infection. Neurology. 50: 1271-80; discussion . PMID 9443448 |
0.069 |
|
| 2006 |
Caplan A, Mobley W. No brainer--can we cope with the ethical ramifications of new knowledge of the human brain? Cerebrum : the Dana Forum On Brain Science. 4: 63. PMID 16619415 |
0.066 |
|
| 2002 |
Iles J, Blakemore C, Gazzaniga MS, Kotulak R, Mobley W. Brain science and public discourse. Cerebrum : the Dana Forum On Brain Science. 4: 68-70. PMID 16619418 |
0.065 |
|
| 2004 |
Rizzo M, Mobley WC. An AUPN/ANA survey of department leader opinions on the health of US academic neurology. Neurology. 63: 1354-6. PMID 15505148 |
0.055 |
|
| 2002 |
Jonsen AR, Churchland PS, Damasio AR, Moreno J, Schaffner KF, Mobley W. Brain science and the self. Cerebrum : the Dana Forum On Brain Science. 4: 56-8. PMID 16619413 |
0.052 |
|
| 2022 |
Riegner G, Posey G, Oliva V, Jung Y, Mobley W, Zeidan F. Disentangling self from pain: mindfulness meditation-induced pain relief is driven by thalamic-default mode network decoupling. Pain. PMID 36095039 DOI: 10.1097/j.pain.0000000000002731 |
0.043 |
|
| 1989 |
De Armond SJ, Gonzales M, Mobley WC, Kon AA, Stern A, Prusiner H, Prusiner SB. PrPSc in scrapie-infected hamster brain is spatially and temporally related to histopathology and infectivity titer. Progress in Clinical and Biological Research. 317: 601-18. PMID 2574872 |
0.042 |
|
| 2002 |
Koenig BA, Greely H, Schacter DL, Winslade WJ, Mobley W. Brain science and social policy. Cerebrum : the Dana Forum On Brain Science. 4: 59-62. PMID 16619414 |
0.037 |
|
| 2009 |
Benedyk M, Berglund L, Facciotti M, Mobley W, Zucker D. Strategies for Innovation and Interdisciplinary Translational Research Journal of Investigative Medicine. 57: 477-481. DOI: 10.2310/Jim.0B013E318198Bcc2 |
0.031 |
|
| 2009 |
Benedyk M, Berglund L, Facciotti M, Mobley W, Zucker D. Strategies for innovation and interdisciplinary translational research: Research and career benefits and barriers Journal of Investigative Medicine. 57: 477-481. PMID 19174698 DOI: 10.2310/Jim.0B013E31819824Be |
0.026 |
|
| 2022 |
Schairer CE, Tutjer J, Cannavino C, Mobley WC, Eyler L, Bloss CS. Learning to Practice Compassionate Care: Medical Students Discuss Their Most Memorable Lessons. Journal of Patient Experience. 9: 23743735221117383. PMID 35957650 DOI: 10.1177/23743735221117383 |
0.026 |
|
| 2003 |
Ward CT, Rey JA, Mobley WC, Evans CDW. Establishing a distance learning site for a traditional doctor of pharmacy program American Journal of Pharmaceutical Education. 67: 153-159. |
0.023 |
|
| 2014 |
Ruparelia A, Mobley WC. Introduction Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders. 15-17. DOI: 10.1016/B978-0-12-398270-4.00002-1 |
0.012 |
|
| 1994 |
Schreier H, Mobley WC, Concessio N, Hickey AJ, Niven RW. Formulation and in vitro performance of liposome powder aerosols S.T.P. Pharma Sciences. 4: 38-44. |
0.011 |
|
| 2002 |
Kennedy D, Mobley W. Are there things we'd rather not know? Cerebrum : the Dana Forum On Brain Science. 4: 67-8. PMID 16619417 |
0.01 |
|
| 2002 |
Mobley WC. Adaptation of a hypertext pharmaceutics course for videoconference-based distance education American Journal of Pharmaceutical Education. 66: 140-143. |
0.01 |
|
| 1998 |
Mobley WC. The effect of jet-milling on lyophilized liposomes. Pharmaceutical Research. 15: 149-52. PMID 9487563 DOI: 10.1023/A:1011929626769 |
0.01 |
|
| 1994 |
Mobley WC, Schreier H. Phase transition temperature reduction and glass formation in dehydroprotected lyophilized liposomes Journal of Controlled Release. 31: 73-87. DOI: 10.1016/0168-3659(94)90253-4 |
0.01 |
|
| Hide low-probability matches. |
